Enhabit (EHAB) Stock Forecast & Price Target

$8.59
+0.34 (+4.12%)
(As of 01:01 PM ET)

Enhabit - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Reduce
Based on 8 Analyst Ratings

Consensus Price Target

$10.13
17.87% Upside
High Forecast$12.00
Average Forecast$10.13
Low Forecast$8.50
TypeCurrent Forecast
5/21/23 to 5/20/24
1 Month Ago
4/21/23 to 4/20/24
3 Months Ago
2/20/23 to 2/20/24
1 Year Ago
5/21/22 to 5/21/23
Consensus Rating
Reduce
Reduce
Reduce
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
2 Buy rating(s)
Hold
7 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
5 Hold rating(s)
Sell
1 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$10.13$12.08$12.80$16.13
Forecasted Upside17.87% Upside16.45% Upside3.63% Upside6.04% Upside
Get Enhabit Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for EHAB and its competitors with MarketBeat's FREE daily newsletter.

EHAB Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EHAB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Enhabit Stock vs. The Competition

TypeEnhabitMedical CompaniesS&P 500
Consensus Rating Score
1.88
2.69
2.49
Consensus RatingReduceModerate BuyHold
Predicted Upside22.43% Upside838.86% Upside7.73% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Recent Analyst Forecasts and Stock Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/14/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
W. Mayo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
5/14/2024SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Market Perform$8.50-1.62%
5/9/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$14.00 ➝ $8.75-9.70%
3/7/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform ➝ Market Perform
3/7/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Neutral$9.50+21.64%
12/12/2023TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$12.00+11.63%
8/11/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$15.00 ➝ $12.00+1.52%
6/20/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageUnderperform$10.00-19.09%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:22 PM ET.

EHAB Frequently Asked Questions

What is Enhabit's stock forecast and purchase recommendation?

According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Enhabit is $10.13, with a high forecast of $12.00 and a low forecast of $8.50. The consensus rating for Enhabit stock is Reduce based on the current 1 sell rating and 7 hold ratings for EHAB. Learn more on EHAB's analyst rating history.

Do Wall Street analysts like Enhabit more than its competitors?

Analysts like Enhabit less than other "medical" companies. The consensus rating for Enhabit is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how EHAB compares to other companies.

Is Enhabit being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, Enhabit's stock had 3 upgrades and 1 downgrade by analysts.

Does Enhabit's stock price have much downside?

According to analysts, Enhabit's stock has a predicted downside of -0.52% based on their 12-month stock forecasts.

What analysts cover Enhabit?

Enhabit has been rated by research analysts at Jefferies Financial Group, Leerink Partnrs, Oppenheimer, SVB Leerink, and UBS Group in the past 90 days.


Stock Forecasts and Research Tools

This page (NYSE:EHAB) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners